Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q1 FY23 results · Apr–Jun 2022
Unichem Laboratories reported revenue from operations of ₹309.61 crore (up 3.9% from Q1 FY22) and net loss of ₹23.37 crore for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 309.61 | 297.91 | +3.9% | 369.95 | −16.3% |
| Other income | 7.85 | 15.79 | −50.3% | 14.39 | −45.5% |
| Total income | 317.46 | 313.70 | +1.2% | 384.34 | −17.4% |
| Profit before tax | (20.67) | (8.97) | Loss widened | 57.94 | Turned loss |
| Net profit for the period | (23.37) | (11.49) | Loss widened | 71.47 | Turned loss |
| EPS, basic (₹) | (3.32) | (1.63) | Loss widened | 10.15 | Turned loss |
| Net margin (%) | -7.5 | -3.9 | 19.3 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 244.78 | 200.80 | +21.9% | 276.86 | −11.6% |
| Other income | 11.85 | 12.54 | −5.5% | 9.08 | +30.5% |
| Total income | 256.63 | 213.34 | +20.3% | 285.94 | −10.3% |
| Profit before tax | (23.28) | (36.38) | Loss narrowed | (0.28) | Loss widened |
| Net profit for the period | (23.28) | (27.83) | Loss narrowed | 17.33 | Turned loss |
| EPS, basic (₹) | (3.31) | (3.95) | Loss narrowed | 2.46 | Turned loss |
| Net margin (%) | -9.5 | -13.9 | 6.3 |
Consolidated
- Filed with BSE
- 10 Aug 2022, 10:04 IST
- Board meeting
- 09 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Aug 2022, 10:04 IST
- Board meeting
- 09 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE